Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Coleman, Coyle, Shuping, and Rue make false statements and draw erroneous conclusions in analyses of abortion and mental health using the National Comorbidity Survey.

Steinberg JR, Finer LB.

J Psychiatr Res. 2012 Mar;46(3):407-8; discussion 408-11. doi: 10.1016/j.jpsychires.2012.01.019. No abstract available.

2.

Examining the association of abortion history and current mental health: A reanalysis of the National Comorbidity Survey using a common-risk-factors model.

Steinberg JR, Finer LB.

Soc Sci Med. 2011 Jan;72(1):72-82. doi: 10.1016/j.socscimed.2010.10.006. Epub 2010 Oct 23.

PMID:
21122964
3.

Induced abortion and anxiety, mood, and substance abuse disorders: isolating the effects of abortion in the national comorbidity survey.

Coleman PK, Coyle CT, Shuping M, Rue VM.

J Psychiatr Res. 2009 May;43(8):770-6. doi: 10.1016/j.jpsychires.2008.10.009. Epub 2008 Nov 28. Erratum in: J Psychiatr Res. 2011 Aug;45(8):1133-4.

PMID:
19046750
4.

Abortion and mental health: findings from The National Comorbidity Survey-Replication.

Steinberg JR, McCulloch CE, Adler NE.

Obstet Gynecol. 2014 Feb;123(2 Pt 1):263-70. doi: 10.1097/AOG.0000000000000092.

5.

Prevalence and predictors of persistent versus remitting mood, anxiety, and substance disorders in a national sample of older adults.

Mackenzie CS, El-Gabalawy R, Chou KL, Sareen J.

Am J Geriatr Psychiatry. 2014 Sep;22(9):854-65. doi: 10.1016/j.jagp.2013.02.007. Epub 2013 Jun 22.

6.

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K.

Arch Gen Psychiatry. 2004 Aug;61(8):807-16.

PMID:
15289279
7.

Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.

Gum AM, King-Kallimanis B, Kohn R.

Am J Geriatr Psychiatry. 2009 Sep;17(9):769-81. doi: 10.1097/JGP.0b013e3181ad4f5a.

PMID:
19700949
8.

Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.

McEvoy PM, Grove R, Slade T.

Aust N Z J Psychiatry. 2011 Nov;45(11):957-67. doi: 10.3109/00048674.2011.624083.

PMID:
22044173
9.

[Other mental disorders presenting together with schizophrenia].

Koponen H, Moilanen K, Isohanni M.

Duodecim. 2003;119(1):43-9. Review. Finnish. No abstract available.

PMID:
12607471
10.

Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.

Teesson M, Slade T, Mills K.

Aust N Z J Psychiatry. 2009 Jul;43(7):606-14. doi: 10.1080/00048670902970908.

PMID:
19530017
11.

Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Smith SM, Stinson FS, Dawson DA, Goldstein R, Huang B, Grant BF.

Psychol Med. 2006 Jul;36(7):987-98. Epub 2006 May 2. Erratum in: Psychol Med. 2008 Apr;38(4):606.

PMID:
16650344
12.

Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.

de Graaf R, Bijl RV, Spijker J, Beekman AT, Vollebergh WA.

Soc Psychiatry Psychiatr Epidemiol. 2003 Jan;38(1):1-11.

PMID:
12563553
13.

Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.

Hall W, Degenhardt L, Teesson M.

Addict Behav. 2009 Jun-Jul;34(6-7):526-30. doi: 10.1016/j.addbeh.2009.03.010. Epub 2009 Mar 24.

PMID:
19386422
15.

Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.

Brady KT, Verduin ML.

Subst Use Misuse. 2005;40(13-14):2021-41, 2043-8. Review.

PMID:
16282091
16.

Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing.

Reavley NJ, Cvetkovski S, Jorm AF, Lubman DI.

Aust N Z J Psychiatry. 2010 Aug;44(8):729-35. doi: 10.3109/00048671003705458.

PMID:
20636194
17.

Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.

de Graaf R, Bijl RV, Ten Have M, Beekman AT, Vollebergh WA.

J Affect Disord. 2004 Nov 1;82(3):461-7.

PMID:
15555699
18.
19.

Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders.

Hill KP.

JAMA. 2017 Mar 14;317(10):1070-1071. doi: 10.1001/jama.2016.19706. No abstract available.

PMID:
28291877
20.

Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.

Schatzberg AF, Weiss RD, Brady KT, Culpepper L.

CNS Spectr. 2008 Apr;13(4 Suppl 6):3. No abstract available.

PMID:
18408653

Supplemental Content

Support Center